Here, we showed that depletion of ESCO2 reduced tumor growth and increased the γH2AX level in the absence of chemotherapy reagents, suggesting that the endogenous ROS-induced DSB damage cannot be properly repaired in ESCO2-depleted cells. The gene discussed is ESCO2; the disease is neoplasm.